Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large-Cell, Anaplastic × carmustine, poliferprosan 20 drug combination × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Rasmussen subacute encephalitis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Plasmablastic Lymphoma 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Myasthenia Gravis 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lambert-Eaton Myasthenic Syndrome 1 Hodgkin Disease 1 HIV Infections 1 Burkitt Lymphoma 1 Autoimmune Diseases of the Nervous System 1 Autoimmune Diseases 1

Interventions

Cyclophosphamide 8 Nivolumab 4 Biopsy 4 fludarabine 3 Specimen Handling 3 Prednisone 3 Magnetic Resonance Spectroscopy 3 Etoposide 3 Doxorubicin 3 Brentuximab Vedotin 3 sodium-iodide symporter 2 pembrolizumab 2 fludarabine phosphate 2 cemiplimab 2 X-Rays 2 Whole-Body Irradiation 2 Vincristine 2 Rituximab 2 Positron-Emission Tomography 2 Photons 2 Mycophenolic Acid 2 Ipilimumab 2 Immunoglobulin G 2 Filgrastim 2 Disulfides 2 Cyclosporine 2 CTLA-4 Antigen 2 10-propargyl-10-deazaaminopterin 2 treosulfan 1 talimogene laherparepvec 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡